Navigation Links
GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season
Date:8/11/2008

GSK anticipates delivery of at least half of shipments by the end of August

PHILADELPHIA, Aug. 11 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that it will begin shipment of FLULAVAL(R) [Influenza Virus Vaccine] and FLUARIX(R) [Influenza Virus Vaccine] to U.S. customers for the 2008-2009 influenza season. The U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) released the first lots of FLULAVAL and FLUARIX, allowing distribution to begin. GSK plans to supply the U.S. market with approximately 35 million doses of the two products combined -- an increase from last year, when GSK contributed approximately 33 million doses.

GSK anticipates delivery of at least half of its influenza vaccines by the end of August and the vast majority to be shipped to customers by the end of September.

"GSK is committed to continually raising awareness of the role of influenza vaccination in helping to keep people healthy," said David Pernock, Senior Vice President, GlaxoSmithKline. "We are excited to play an integral part in helping adults protect themselves against this serious infection."

FLUARIX is available for purchase on GSKVaccinesDirect.com. FLULAVAL is available for purchase on GSKVaccinesDirect.com or through three distributors -- Henry Schein, Inc., McKesson Medical-Surgical and ASD Specialty Healthcare.

About Influenza

Influenza, or the flu, is primarily passed from one person to another through the air by droplets released when an infected individual coughs or sneezes, but may also be spread by direct contact with flu virus-contaminated surfaces.

According to the U.S. Centers for Disease Control and Prevention (CDC), annual flu vaccination is the most effective method for preventing flu virus infection and its complications. The CDC recommends an annual flu vaccination for anyone who wishes to reduce their risk of contracting the flu -- especially adults ov
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Biologic Products Begins Annual Maintenance of its Production Facilities
2. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
3. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
4. China Biologic Products Begins Operation of its Newly Constructed Plasma Collection Station in Qi He County, Shandong Province
5. Medimetriks Pharmaceuticals, Inc. Begins Operations
6. CardioDynamics Shareholders Approve One-for-Seven Reverse Split of Companys Common Stock and Trading in Post-split Shares Begins May 9, 2008
7. Nikon Instruments Begins Direct Sales and Technical Support in Southern California and Rocky Mountain Territories
8. Thomson Scientific Begins Expansion of Web of Science
9. Ohio Task Force Begins Mission of Creating a New 21st Century Industry
10. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
11. SPO Medical Begins Shipping PulseOx 6000(TM) and PulseOx 6100(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)...  ( www.competitivehealth.com ) — Competitive Health is pleased ... and advocacy service, has signed an agreement to become ... health services marketplace. 63% of Americans have ... expected to pay. As part of an ongoing effort ... is pleased to offer medical bill review and negotiation ...
(Date:12/22/2014)... Fertility Associates of Memphis has announced a ... a network of more than 20 contributing fertility ... fast access to a national pool of frozen ... Associates of Memphis is the only fertility clinic in ... Dr. William Kutteh , director of Fertility Associates ...
(Date:12/19/2014)... December 19, 2014 BioPlus Specialty ... pharmacies, announces the promotion of Nick Maroulis, Pharm.D. to ... Pharmacy Services. , In this position, Dr. Maroulis ... also managing the directors of our multi-site pharmacies as ... since 1997 and during that time he has served ...
(Date:12/19/2014)... , Dec. 19, 2014 Bina Technologies, Inc. ... announced today that they have been acquired by Roche ... is a privately held company that provides a big ... generation sequencing (NGS) data for the academic and translational ... Sequencing Unit, and will continue to focus on development ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... Corporation (NYSE:,DHR) announced that President and Chief Executive ... the J.P. Morgan Healthcare Conference in,San Francisco on ... audio will be,simultaneously webcast on http://www.danaher.com . ... for one week., Danaher Corporation is a ...
... China Technology,Development Group Corporation (Nasdaq: CTDC; "the Company" ... products and solutions focusing on,solar energy business in ... ceremony to showcase the first SnO2 production line ... 2007., Accompanied by Mr. Alan Li, our ...
... 3 Neogen Corporation,(Nasdaq: NEOG ) announced today ... 2008, which ended Nov. 30, increased 34% from the ... net income in the,quarter rose to $0.22 per share, ... income of $3,254,000 set another quarterly,record for the 25-year-old ...
Cached Biology Technology:CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line 2CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line 3Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues 2Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues 3Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues 4Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues 5
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/18/2014)...   News Highlights: ... The Partners Data Lake, an agile data and ... will allow researcher and clinicians to explore and ... lives of patients , The Partners Data ... the Partners system, breaking down physical barriers for ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... the world,s two best-loved flavours and demand for it is ... global food industry could be more secure, thanks to research ... a compound that comes from the vanilla bean, the ,fruit, ... climbing vine originally cultivated by ancient Central American civilisations such ...
... An experimental drug that blocks two points of a ... ovarian cancer cells and significantly increases survival in an ... Comprehensive Cancer Center has found. The drug, called ... have become resistant to the conventional treatment with platinum ...
... gene defect in Wiskott-Aldrich syndrome, an inherited immune deficiency disorder, researchers ... in a 13-year-old boy with the disease. The study, at The ... elements of the body,s immune system, may be used to treat ... ...
Cached Biology News:Preserving a world favorite flavour 2Experimental drug inhibits cell signaling pathway and slows ovarian cancer growth 2Novel therapy improves immune function in teen with rare disease 2
Kinase Buffer can be used to assay protein kinase activity...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: